Parenteral product quality is improving. Since 2014, when USP <790> “Visible Particulates in Injections” (1) became official, particle-related recalls of injectable products have dropped significantly ...
Automatic visual inspection machines and artificial intelligence highlight inspection deficits for parenteral containers and units. As a mandatory practice for injectable drug products by both FDA and ...
If you’re producing small precision components, quality drives the entire manufacturing process. One of the ways to help ensure the quality of such products is through the use of automated inspection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback